CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growthYihua Lin(Guangdong Pharmaceutical University), Qianqian Zhang(Guangdong Pharmaceutical University)BMC CancerMay 26, 202310.1186/s12885-023-10974-4Cited by 6SaveCiteExport RISWatch citationsRelated PapersActivation of Slit2/Robo1 Signaling Promotes Tumor Metastasis in Colorectal Carcinoma through Activation of the TGF-β/Smads Pathway|Cells|2019|21